133 related articles for article (PubMed ID: 14766003)
1. Androgen inhibition of MAP kinase pathway and Elk-1 activation in proliferating osteoblasts.
Wiren KM; Toombs AR; Zhang XW
J Mol Endocrinol; 2004 Feb; 32(1):209-26. PubMed ID: 14766003
[TBL] [Abstract][Full Text] [Related]
2. Osteoblast and osteocyte apoptosis associated with androgen action in bone: requirement of increased Bax/Bcl-2 ratio.
Wiren KM; Toombs AR; Semirale AA; Zhang X
Bone; 2006 May; 38(5):637-51. PubMed ID: 16413235
[TBL] [Abstract][Full Text] [Related]
3. Effects of gonadal and adrenal androgens in a novel androgen-responsive human osteoblastic cell line.
Hofbauer LC; Hicok KC; Khosla S
J Cell Biochem; 1998 Oct; 71(1):96-108. PubMed ID: 9736458
[TBL] [Abstract][Full Text] [Related]
4. Nongenomic androgen activation of phosphatidylinositol 3-kinase/Akt signaling pathway in MC3T3-E1 osteoblasts.
Kang HY; Cho CL; Huang KL; Wang JC; Hu YC; Lin HK; Chang C; Huang KE
J Bone Miner Res; 2004 Jul; 19(7):1181-90. PubMed ID: 15177002
[TBL] [Abstract][Full Text] [Related]
5. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M
Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214
[TBL] [Abstract][Full Text] [Related]
6. The anti-androgen hydroxyflutamide and androgens inhibit interleukin-6 production by an androgen-responsive human osteoblastic cell line.
Hofbauer LC; Ten RM; Khosla S
J Bone Miner Res; 1999 Aug; 14(8):1330-7. PubMed ID: 10457265
[TBL] [Abstract][Full Text] [Related]
7. Development and characterization of a conditionally immortalized human osteoblastic cell line stably transfected with the human androgen receptor gene.
Hofbauer LC; Hicok KC; Schroeder MJ; Harris SA; Robinson JA; Khosla S
J Cell Biochem; 1997 Sep; 66(4):542-51. PubMed ID: 9282332
[TBL] [Abstract][Full Text] [Related]
8. Androgens induce divergent proliferative responses in human breast cancer cell lines.
Birrell SN; Bentel JM; Hickey TE; Ricciardelli C; Weger MA; Horsfall DJ; Tilley WD
J Steroid Biochem Mol Biol; 1995 May; 52(5):459-67. PubMed ID: 7748811
[TBL] [Abstract][Full Text] [Related]
9. Grape seed extract inhibits EGF-induced and constitutively active mitogenic signaling but activates JNK in human prostate carcinoma DU145 cells: possible role in antiproliferation and apoptosis.
Tyagi A; Agarwal R; Agarwal C
Oncogene; 2003 Mar; 22(9):1302-16. PubMed ID: 12618755
[TBL] [Abstract][Full Text] [Related]
10. Development of two androgen receptor assays using adenoviral transduction of MMTV-luc reporter and/or hAR for endocrine screening.
Hartig PC; Bobseine KL; Britt BH; Cardon MC; Lambright CR; Wilson VS; Gray LE
Toxicol Sci; 2002 Mar; 66(1):82-90. PubMed ID: 11861975
[TBL] [Abstract][Full Text] [Related]
11. Activation of mitogen-activated protein kinase pathway by the antiandrogen hydroxyflutamide in androgen receptor-negative prostate cancer cells.
Lee YF; Lin WJ; Huang J; Messing EM; Chan FL; Wilding G; Chang C
Cancer Res; 2002 Nov; 62(21):6039-44. PubMed ID: 12414626
[TBL] [Abstract][Full Text] [Related]
12. Rapid signalling by androgen receptor in prostate cancer cells.
Peterziel H; Mink S; Schonert A; Becker M; Klocker H; Cato AC
Oncogene; 1999 Nov; 18(46):6322-9. PubMed ID: 10597231
[TBL] [Abstract][Full Text] [Related]
13. Androgens activate mitogen-activated protein kinase signaling: role in neuroprotection.
Nguyen TV; Yao M; Pike CJ
J Neurochem; 2005 Sep; 94(6):1639-51. PubMed ID: 16011741
[TBL] [Abstract][Full Text] [Related]
14. Androgens stimulate hypoxia-inducible factor 1 activation via autocrine loop of tyrosine kinase receptor/phosphatidylinositol 3'-kinase/protein kinase B in prostate cancer cells.
Mabjeesh NJ; Willard MT; Frederickson CE; Zhong H; Simons JW
Clin Cancer Res; 2003 Jul; 9(7):2416-25. PubMed ID: 12855613
[TBL] [Abstract][Full Text] [Related]
15. Androgens activate mitogen-activated protein kinase via epidermal growth factor receptor/insulin-like growth factor 1 receptor in the mouse PC-1 cell line.
Hamzeh M; Robaire B
J Endocrinol; 2011 Apr; 209(1):55-64. PubMed ID: 21220406
[TBL] [Abstract][Full Text] [Related]
16. Fibroblast growth factor receptor signaling activates the human interstitial collagenase promoter via the bipartite Ets-AP1 element.
Newberry EP; Willis D; Latifi T; Boudreaux JM; Towler DA
Mol Endocrinol; 1997 Jul; 11(8):1129-44. PubMed ID: 9212060
[TBL] [Abstract][Full Text] [Related]
17. Dehydroepiandrosterone improves murine osteoblast growth and bone tissue morphometry via mitogen-activated protein kinase signaling pathway independent of either androgen receptor or estrogen receptor.
Wang L; Wang YD; Wang WJ; Zhu Y; Li DJ
J Mol Endocrinol; 2007 Apr; 38(4):467-79. PubMed ID: 17446236
[TBL] [Abstract][Full Text] [Related]
18. Androgens stimulate erythropoiesis through the DNA-binding activity of the androgen receptor in non-hematopoietic cells.
McManus JF; Nguyen NN; Davey RA; MacLean HE; Pomilio G; McCormack MP; Chiu WS; Wei AH; Zajac JD; Curtis DJ
Eur J Haematol; 2020 Sep; 105(3):247-254. PubMed ID: 32311143
[TBL] [Abstract][Full Text] [Related]
19. Dihydrotestosterone differentially modulates the mitogen-activated protein kinase and the phosphoinositide 3-kinase/Akt pathways through the nuclear and novel membrane androgen receptor in C6 cells.
Gatson JW; Kaur P; Singh M
Endocrinology; 2006 Apr; 147(4):2028-34. PubMed ID: 16410299
[TBL] [Abstract][Full Text] [Related]
20. Androgen-dependent cell cycle arrest and apoptotic death in PC-3 prostatic cell cultures expressing a full-length human androgen receptor.
Heisler LE; Evangelou A; Lew AM; Trachtenberg J; Elsholtz HP; Brown TJ
Mol Cell Endocrinol; 1997 Jan; 126(1):59-73. PubMed ID: 9027364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
